Cargando…

A Multi-Technique Investigation of the Complex Formation Equilibria between Bis-Deferiprone Derivatives and Oxidovanadium (IV)

The increasing biomedical interest in high-stability oxidovanadium(IV) complexes with hydroxypyridinone ligands leads us to investigate the complex formation equilibria of V(IV)O(2+) ion with a tetradentate ligand, named KC21, which contains two 3-hydroxy-1,2-dimethylpyridin-4(1H)-one (deferiprone)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cappai, Rosita, Fantasia, Alessandra, Crisponi, Guido, Garribba, Eugenio, Santos, M. Amélia, Nurchi, Valeria Marina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924880/ https://www.ncbi.nlm.nih.gov/pubmed/35268654 http://dx.doi.org/10.3390/molecules27051555

Ejemplares similares

Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach
por: Cappai, Rosita, et al.
Publicado: (2021)

Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme
por: Ferraro, Giarita, et al.
Publicado: (2022)

ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins
por: Ugone, Valeria, et al.
Publicado: (2020)

Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP
por: Sciortino, Giuseppe, et al.
Publicado: (2020)

A Review on Coordination Properties of Thiol-Containing Chelating Agents Towards Mercury, Cadmium, and Lead
por: Bjørklund, Geir, et al.
Publicado: (2019)

Chelating Agents in Soil Remediation: A New Method for a Pragmatic Choice of the Right Chelator
por: Nurchi, Valeria Marina, et al.
Publicado: (2020)

Di-μ-chlorido-bis[diacetonitrilechloridooxidovanadium(IV)]
por: Dastych, Dalibor, et al.
Publicado: (2011)

Oxovanadium(IV) Coordination Compounds with Kojic Acid Derivatives in Aqueous Solution
por: Berto, Silvia, et al.
Publicado: (2019)

Gold Nanoparticles: A New Golden Era in Oncology?
por: Gerosa, Clara, et al.
Publicado: (2020)

A Friendly Complexing Agent for Spectrophotometric Determination of Total Iron
por: Nurchi, Valeria M., et al.
Publicado: (2021)

trans-Bis(1,3-diphenylpropane-1,3-dionato)(methanol)oxidovanadium(IV) methanol disolvate
por: Pretorius, Carla, et al.
Publicado: (2012)

cis-Dichloridobis(ethyl methyl sulfide-κS)oxidovanadium(IV)
por: Matsuura, Masatoshi, et al.
Publicado: (2013)

Exploring Oxidovanadium(IV) Complexes as YopH Inhibitors: Mechanism of Action and Modeling Studies
por: Martins, Priscila G. A., et al.
Publicado: (2015)

Bis(4,4′-dimethyl-2,2′-bipyridine)oxidovanadium(IV) Sulfate Dehydrate: Potential Candidate for Controlling Lipid Metabolism?
por: Francik, Renata, et al.
Publicado: (2017)

Ligand substitution reactions of a phenolic quinolyl hydrazone; oxidovanadium (IV) complexes
por: Seleem, Hussein S, et al.
Publicado: (2011)

Redetermination of μ-oxido-bis[bis(N,N-diethylhydroxylaminato)oxidovanadium(V)]
por: Zhang, Heng-Qiang, et al.
Publicado: (2011)

Structurally Characterized BODIPY-Appended Oxidovanadium(IV) β-Diketonates for Mitochondria-Targeted Photocytotoxicity
por: Bhattacharyya, Utso, et al.
Publicado: (2020)

A Speciation Study on the Perturbing Effects of Iron Chelators on the Homeostasis of Essential Metal Ions
por: Crisponi, Guido, et al.
Publicado: (2015)

The Aging Kidney—As Influenced by Heavy Metal Exposure and Selenium Supplementation
por: Aaseth, Jan, et al.
Publicado: (2021)

Arsenic Toxicity: Molecular Targets and Therapeutic Agents
por: Nurchi, Valeria M., et al.
Publicado: (2020)

(2,2′-Bipyridine)(pyridine-2,6-dicarboxylato)oxidovanadium(IV) ethanol monosolvate
por: Aghabozorg, Hossein, et al.
Publicado: (2011)

On the Capability of Oxidovanadium(IV) Derivatives to Act as All-Around Catalytic Promoters Since the Prebiotic World
por: Campitelli, Patrizio, et al.
Publicado: (2020)

Bis(acetylacetonato-κ(2) O,O′)(2-amino-1-methyl-1H-benzimidazole-κN (3))oxidovanadium(IV)
por: Kadirova, Zukhra Ch., et al.
Publicado: (2009)

Crystal structure of bis[μ-2-(diisopropylphosphoryl)propan-2-olato-κ(3) O (1),O (2):O (1)]bis[chloridooxidovanadium(IV)]
por: Glatz, Mathias, et al.
Publicado: (2016)

A Novel Oxidovanadium (IV)-Orotate Complex as an Alternative Antidiabetic Agent: Synthesis, Characterization, and Biological Assessments
por: Naglah, Ahmed M., et al.
Publicado: (2018)

QSAR Modeling, Molecular Docking and Cytotoxic Evaluation for Novel Oxidovanadium(IV) Complexes as Colon Anticancer Agents
por: Alomari, Fatimah Y., et al.
Publicado: (2022)

Salmonella Typhimurium and Pseudomonas aeruginosa Respond Differently to the Fe Chelator Deferiprone and to Some Novel Deferiprone Derivatives
por: Ammendola, Serena, et al.
Publicado: (2021)

Theoretical Investigation by DFT and Molecular Docking of Synthesized Oxidovanadium(IV)-Based Imidazole Drug Complexes as Promising Anticancer Agents
por: Basaleh, Amal S., et al.
Publicado: (2022)

A binuclear vanadium oxyfluoride: di-μ-oxido-bis[(2,2′-bipyridyl)fluoridooxidovanadium(V)]
por: DeBurgomaster, Paul, et al.
Publicado: (2010)

Crystal structure of (μ-hydrogen disulfato)-μ-oxido-bis[(4,4′-di-tert-butyl-2,2′-bipyridine)oxidovanadium(IV/V)] acetonitrile monosolvate
por: Kodama, Shintaro, et al.
Publicado: (2023)

Prospective comparison on cardiac iron by MR in thalassemia major patients treated with combination deferipron-desferrioxamine versus deferipron and desferrioxamine in monoterapy
por: Pepe, Alessia, et al.
Publicado: (2011)

CHEMOTHERAPEUTIC EQUILIBRIA
por: Stearn, Allen E., et al.
Publicado: (1930)

{2,2′-[Ethylenebis(nitrilomethylidyne)]diphenolato-κ(4) O,N,N′,O′}oxidovanadium(IV)
por: Wang, Cheng, et al.
Publicado: (2008)

Spectroscopic/Computational Characterization and the X-ray Structure of the Adduct of the V(IV)O–Picolinato Complex with RNase A
por: Ferraro, Giarita, et al.
Publicado: (2021)

Thermodynamic Equilibria and Extrema: Analysis of Attainability Regions and Partial Equilibria
por: Gorban, Alexander N, et al.
Publicado: (2006)

Implications of Protein Interaction in the Speciation of Potential V(IV)O–Pyridinone Drugs
por: Ferraro, Giarita, et al.
Publicado: (2023)

Deferiprone targets aconitase: Implication for Friedreich's ataxia treatment
por: Goncalves, Sergio, et al.
Publicado: (2008)

Quantum chemical analysis of the deferiprone–iron binding reaction
por: Wiwanitkit, Viroj
Publicado: (2006)

Effect of Iron-Chelator Deferiprone on the In Vitro Growth of Staphylococci
por: Kim, Choon-Mee, et al.
Publicado: (2009)

Deferiprone‐induced agranulocytosis: 20 years of clinical observations
por: Tricta, Fernando, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0optco77k40i74plf6j6b1feg5